Harfst & Associates’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-10,531
Closed -$519K 100
2019
Q2
$519K Buy
10,531
+1,666
+19% +$84.7K 0.21% 66
2019
Q1
$424K Buy
8,865
+1,630
+23% +$98.8K 0.18% 66
2018
Q4
$443K Buy
7,235
+665
+10% +$44.9K 0.21% 56
2018
Q3
$541K Buy
6,570
+181
+3% +$14.4K 0.23% 39
2018
Q2
$499K Buy
6,389
+38
+0.6% +$2.94K 0.21% 36
2018
Q1
$468K Buy
6,351
+209
+3% +$14.8K 0.19% 40
2017
Q4
$419K Buy
6,142
+163
+3% +$10.5K 0.17% 48
2017
Q3
$367K Buy
5,979
+32
+0.5% +$1.96K 0.15% 53
2017
Q2
$373K Buy
+5,947
New +$339K 0.15% 45

Other funds holding NUS

Harfst & Associates's NUS Position: Q3 2019 in Review

Harfst & Associates sold out of Nu Skin (NUS) in Q3 2019, closing a stake of 10,531 shares — an estimated $519K sold.

Harfst & Associates first reported a position in NUS in Q2 2017 and held it in 9 quarters. The position peaked at $541K in Q3 2018. 235 funds tracked by Wall St. Rank hold NUS as of Q3 2019.

  • Harfst & Associates reported no remaining Nu Skin position as of Q3 2019 after selling out during the quarter.
  • Harfst & Associates sold 10,531 Nu Skin shares in Q3 2019, an estimated $519K.
  • Harfst & Associates first reported a position in Nu Skin in Q2 2017 and held it in 9 quarters.
  • Harfst & Associates's Nu Skin position peaked at $541K in Q3 2018.
  • 235 funds tracked by Wall St. Rank held Nu Skin as of Q3 2019.

Based on Harfst & Associates's 13F filing for Q3 2019, filed 14 Nov 2019.